Consensus $328.42M. Raises FY24 adjusted EBITDA view to $25M-$26M from $18M-$22M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on CDNA: CareDx sees Q4 revenue $85M-$86M, consensus $82.16M CareDx Updates Director Compensation and Vesting Policies TC Biopharm announces partnership with CareDx CareDx management to meet with Craig Hallum
